Last reviewed · How we verify
CEUS or Contrast enhanced Ultrasound
At a glance
| Generic name | CEUS or Contrast enhanced Ultrasound |
|---|---|
| Also known as | Ultrasound, CEUS with Lumason |
| Sponsor | Mayo Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases (NA)
- Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses (PHASE1)
- Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound
- Neonatal Brain Ultrasound With CEUS and Elastography (PHASE3)
- Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
- Comparison of Ultrasound Cerebral Perfusion Imaging With Routine Perfusion CT (NA)
- Contrast-enhanced Ultrasound for Sentinel Node Detection (PHASE2, PHASE3)
- Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CEUS or Contrast enhanced Ultrasound CI brief — competitive landscape report
- CEUS or Contrast enhanced Ultrasound updates RSS · CI watch RSS
- Mayo Clinic portfolio CI